David Leverenz

CD40L Inhibitor in Sjogren's - RheumMadness Team: CD40L Inhibitor in Sjögren’s, aka the “Sjögren Horse” Base article: St Clair EW, Baer AN, Ng WF, et al. CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, pla...

For me it's more like DAZ is Hector's Shield. #RheumMadness #GreekMythology

sites.duke.edu/rheummadness...

5.2 T'd Up T-Cells - RheumMadness Podcast In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational.  This is the first of a two-part conversation with the authors of the scouting reports ...

ListeningRheum👂notes: #RheumMadness

🤔CD40L pathway has potential in SLE 🦋 #Dapirolizumab-pegol

#ACR24 abs: acrabstracts.org/abstract/dap...

📻https://rheummadness.buzzsprout.com/1465681/episodes/16400130-5-2-t-d-up-t-cells?t=0

a man walking on a basketball court with a spalding sign behind him ALT: a man walking on a basketball court with a spalding sign behind him

The Full Court Care Champions of #RheumMadness 2025 are here!

This region explores cost-effective HCQ screening, optimal prednisone dosing in SLE, and better GCA detection.

Check it out here 👇
sites.duke.edu/rheummadness/

We had so much fun recording this week's @rheummadness.bsky.social podcast episode to talk about our #RheumMadness scouting report on "Steroid Dose in Lupus Nephritis"! You can find our scouting report here: sites.duke.edu/rheummadness... and the first half of the "Full Court Care Champions" (1/2)

5.4 Cytokine Crushers - RheumMadness Podcast In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, ...

Plus a new #RheumMadness podcast episode!

www.buzzsprout.com/1465681/epis...

a man and a woman are standing in the jungle and the woman is saying yes . ALT: a man and a woman are standing in the jungle and the woman is saying yes .

Scouting reports for the 👊 cytokine crushers 👊 region of #RheumMadness 2025 are out!

Find them 👇
sites.duke.edu/rheummadness/

5.3 T'd Up T-Cells Part 2 - RheumMadness Podcast In this episode, we present the second part of our conversation with the authors of the scouting reports for the teams in the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational.&n...

New #RheumMadness podcast episode! This one is long, but you're crazy about rheumatology so who cares?

In this episode:
-Q&As from theMednet.org
-Primer on T-cell co-stimulation
-Analysis of APIPPRA
-Interview with lead author of DAZ study

To listen 👇
www.buzzsprout.com/1465681/epis...

Enjoying the #RheumMadness T'd Up T-Cells region? Explore the topics further at theMednet.org

Each team is paired with high-yield Q&As like:
-Approach to sicca
-Approach to pre-RA
-T vs. B-cell therapies in refractory SLE

See link 👇
www.themednet.org/v2/programs/...

Great time on the @rheummadness.bsky.social pod last night talking about our scouting report for the #RheumMadness season! Glad to see our friends from Duke, MCW & Main Line Health & talk #RheumResearch! Episode drops 2/5/25!
⛹️‍♀️🏀

#Rheumsky @sambhawanabhandari.bsky.social @laceyfeigl.bsky.social

Another #RheumMadness podcast recording is in the books! This one covered the Full Court Care Champions region, scheduled to be released in February, with many more episodes to be released between now and then!

Thanks to the MCW, WUSTL, and Lankenau teams for joining this one!

🔥 Prepare for this year's #RheumMadness by @rheummadness.bsky.social !
Sign up for the newsletter at:
lists.duke.edu/sympa/subscr...
Where academic rheumatology teams compete in March similar to basketball madness. Get your teams ready, I can't wait to see the chosen papers for this year!

Diamond dogs assemble!

New #RheumMadness content is coming next week, including the return of the 🎙️ podcast 🎙️

We had to transition to a new newsletter service. Even if you've subscribed before, please re-subscribe at the link below so you don't miss any content!
👇👇👇
lists.duke.edu/sympa/subscr...